Janeen Doyle is currently serving as the Chief Corporate and Business Development Officer at Janux Therapeutics, a position held since May 2025. Prior to this role, Janeen was a Senior Partner and Senior Vice President for Corporate Partnerships & Program Development at Flagship Pioneering from June 2024 to May 2025. Between November 2019 and June 2024, Janeen held several senior leadership positions at Bristol Myers Squibb, including Senior Vice President of Strategy Business Development and Vice President of Business Development & Global Alliances, Research & Early Development. Janeen's extensive experience in the pharmaceutical industry includes significant roles at Celgene, Regeneron, Altana Pharma, and Schering-Plough Pharmaceuticals. Janeen holds an M.B.A. in Business Administration and Management from the University of Scranton and a B.S. in Biology from Moravian University.
This person is not in any teams
This person is not in any offices